Longport Names Dr. Mary Dyson Executive Vice President.
SWARTHMORE, Pa.--(BUSINESS WIRE)--June 6, 2000
Longport, Inc. (OTCBB: LPTI, Pacific: LDS.P) today announced the Company has named Dr. Mary Dyson as Executive Vice President.
Dr. Mary Dyson, B. Sc, Ph.D., C.Biol., F.A.I.U.M. (Hon.)., was formally Longport's Biomedical Consultant. From 1987 to 1998, Dr. Dyson served as head of the Tissue Repair Research Unit of the Division of Anatomy and Cell Biology for the United Medical and Dental Schools of Guy's and St. Thomas' Hospitals in London, England. Prior to this, she was a Senior Lecturer in anatomy at Guy's Hospital Medical School. She is currently Emeritus Reader in the Biology of Tissue Repair at Kings College London, Honorary Reader at the Department of Physiology, University College, London, and a visiting Professor at the University of Ulster. Dr. Dyson has received numerous academic awards, including being elected an Honorary Fellow of the Chartered Society of Physiotherapy for research into the biological effects of electrotherapy and being elected an Honorary Fellow of the American Institute for Ultrasound in Medicine for `outstanding contributions in the field of medical ultrasound'. Dr. Dyson's editorial positions include being a member of the Advisor Editorial Board of "Ultrasound in Medicine and Biology" since 1977, a co-editor of "Gray's Anatomy" 37th Edition, and a member of the Editorial Board of "Gray's Anatomy" 38th Edition. She is currently a member of the Editorial Boards for "Laser Therapy" and "Physiotherapy Reviews". Dr. Dyson served as president of the International Laser Therapy Association from 1990 to 1992, and currently is a member of numerous other associations, including the World Association for Laser Therapy, the British Medical Ultrasound Society, and the British Society for Cell Biology. Dr. Dyson has had numerous articles published in the areas of Tissue Repair, Ultrasound and Laser Bioeffects, and maintains an active international lecturing schedule. Dr. Dyson received her Ph.D. and B.Sc. from Bedford College, University of London.
Longport, Inc., is the developer of the Longport Digital Scanner (LDS), a high resolution, portable, digital ultrasound scanner that captures and reproduces images of soft tissue down to approximately 2 cm. The images are stored in a portable computer and can be e-mailed off-site for interpretation. The company has developed the LDS with multiple applications in mind, including wound management, identification of potential pressure ulcers and detection of metastasizing cancer in patients diagnosed with cutaneous malignant melanoma. The chief advantage to this process it that this type of imaging allows the clinician to do a soft tissue assessment non-invasively.
For additional information, to receive a video, and/or to add your name to receive information about Longport, please call CFSG at 1-800-625-2236. Visit Longport's website at www.longportinc.com.
This press release contains forward-looking statements that, if not verifiable historical fact, may be viewed as forward-looking statements that could predict future events or outcomes with respect to Longport, Inc. and its business. The predictions embodied in these statements will involve risks and uncertainties and accordingly, Longport's actual results may differ significantly from the results discussed or implied in such forward-looking statements.
|Printer friendly Cite/link Email Feedback|
|Date:||Jun 6, 2000|
|Previous Article:||NetStaff Direct Access Interview to be Broadcast by Investor Broadcast Network Over the Internet.|
|Next Article:||American Water Works Company, Inc. Supports New Public Notication Regulations.|